Overview Target Drug Modality Indication Mechanism of Action Status Data Drug Name H-05 Description The hepatitis B virus (HBV) belongs to oncogenic viruses that cause hepatocellular cancer (HCC). The global prevalence of hepatitis B infection was estimated to be 356 million in 2015. Nucleoside/nucleotide antivirals as the major drugs can suppress hepatitis B virus (HBV) …
https://www.protheragen.com/av...